BeOne Medicines (ONC) Total Non-Current Liabilities (2015 - 2026)
BeOne Medicines' (ONC) quarterly Total Non-Current Liabilities came in at $1.9 billion in Q2 2026, up 491.81% year-over-year from $318.1 million in Q2 2025, and down 5.01% quarter-over-quarter from $2.0 billion in Q1 2026.
Powered by 
Analysis
BeOne Medicines (ONC) Total Non-Current Liabilities (2015 - 2026) Analysis & Trends
BeOne Medicines (ONC) has reported Total Non-Current Liabilities for 12 consecutive years, with $1.9 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Total Non-Current Liabilities rose 491.81% year-over-year to $1.9 billion in Q2 2026; TTM through Jun 2026 was $1.9 billion, a 491.81% increase from a year earlier, with the FY2025 full-year figure at $2.0 billion, up 434.67% from the prior year.
- Total Non-Current Liabilities was $1.9 billion for Q2 2026 at BeOne Medicines, down from $2.0 billion in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $2.0 billion in Q4 2025 and troughed at $318.1 million in Q2 2025.
- A 5-year average of $771.1 million and a median of $526.2 million in 2022 frame the typical range for Total Non-Current Liabilities.
- Across the five-year window, Total Non-Current Liabilities slumped 34.35% in 2022 and jumped 491.81% in 2026, its largest moves.
- Over 5 years, Total Non-Current Liabilities stood at $527.4 million in 2022, then retreated by 13.19% to $457.8 million in 2023, then fell by 18.36% to $373.8 million in 2024, then soared by 434.67% to $2.0 billion in 2025, then declined by 5.81% to $1.9 billion in 2026.
- The last three Total Non-Current Liabilities figures came in at $1.9 billion (Q2 2026), $2.0 billion (Q1 2026), and $2.0 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 105.99 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | 106.45 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | 16.16 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | 48.34 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | -967.00 Mn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 81.11 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | 36.04 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | 100.86 Bn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 5.92 Bn |
| 10 | BeOne Medicines | 41.25 Bn | 36.15 Bn | 1.53 Bn | 1.88 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.88 Bn |
| Mar 31, 2026 | 1.98 Bn |
| Dec 31, 2025 | 2.00 Bn |
| Sep 30, 2025 | 1.13 Bn |
| Jun 30, 2025 | 318.08 Mn |
| Mar 31, 2025 | 358.29 Mn |
| Dec 31, 2024 | 373.79 Mn |
| Sep 30, 2024 | 369.46 Mn |
| Jun 30, 2024 | 407.16 Mn |
| Mar 31, 2024 | 425.63 Mn |
| Dec 31, 2023 | 457.84 Mn |
| Sep 30, 2023 | 478.35 Mn |
| Jun 30, 2023 | 525.07 Mn |
| Mar 31, 2023 | 544.92 Mn |
| Dec 31, 2022 | 527.41 Mn |
| Sep 30, 2022 | 659.53 Mn |
| Jun 30, 2022 | 677.25 Mn |
| Mar 31, 2022 | 759.58 Mn |
| Dec 31, 2021 | 803.41 Mn |
| Sep 30, 2021 | 624.83 Mn |
API Access
BeOne Medicines Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ONC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "ONC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ONC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();